These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29195607)

  • 1. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Webber C; Patton M; Bonten MJM;
    Vaccine; 2017 Dec; 35(51):7078. PubMed ID: 29195607
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Webber C; Patton M; Patterson S; Schmoele-Thoma B; Huijts SM; Bonten MJ;
    Vaccine; 2017 Mar; 35(9):1266-1272. PubMed ID: 28173960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults.
    Isturiz R; Webber C
    Hum Vaccin Immunother; 2015; 11(7):1825-7. PubMed ID: 26076136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay.
    Pletz MW; Ewig S; Rohde G; Schuette H; Rupp J; Welte T; Suttorp N; Forstner C;
    Vaccine; 2016 Apr; 34(20):2342-8. PubMed ID: 27016653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal vaccination in older adults.
    Marras TK
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924340
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines.
    Principi N; Esposito S
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
    van Werkhoven CH
    Hum Vaccin Immunother; 2017 May; 13(5):1177-1181. PubMed ID: 27937061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal conjugate vaccine use in adults.
    Isturiz RE; Schmoele-Thoma B; Scott DA; Jodar L; Webber C; Sings HL; Paradiso P
    Expert Rev Vaccines; 2016; 15(3):279-93. PubMed ID: 26651847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal vaccination in adults.
    Rashid H; Shafi S; Haworth E; Booy R
    Arch Intern Med; 2008 Mar; 168(6):666-7. PubMed ID: 18362261
    [No Abstract]   [Full Text] [Related]  

  • 10. The Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA): what is the future of pneumococcal conjugate vaccination in elderly?
    van Werkhoven CH; Bonten MJ
    Future Microbiol; 2015; 10(9):1405-13. PubMed ID: 26347153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: In COPD, injectable polyvalent pneumococcal vaccines reduce risk for community-acquired pneumonia.
    Stanbrook MB
    Ann Intern Med; 2017 May; 166(10):JC52. PubMed ID: 28505636
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
    Simberkoff MS
    Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tale of 2 pneumococcal vaccines.
    Klugman KP
    Clin Infect Dis; 2014 Apr; 58(7):925-7. PubMed ID: 24532545
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia.
    Sanz-Herrero F; Gimeno-Cardona C; Tormo-Palop N; Fernández-Fabrellas E; Briones ML; Cervera-Juan Á; Blanquer-Olivas J
    Vaccine; 2016 Apr; 34(15):1847-52. PubMed ID: 26845737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention is better than cure: time to change the focus of community-acquired pneumonia management.
    Welte T
    Eur Respir J; 2015 Jun; 45(6):1524-5. PubMed ID: 26028615
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens.
    Wagenvoort GHJ; Vlaminckx BJM; van Kessel DA; Geever RCL; de Jong BAW; Grutters JC; Bos WJW; Meek B; Rijkers GT
    Vaccine; 2017 Sep; 35(37):4886-4895. PubMed ID: 28802755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal vaccines for older adults: getting the timing right.
    Campos-Outcalt D
    J Fam Pract; 2014 Dec; 63(12):730-3. PubMed ID: 25486320
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcomes in community-acquired pneumonia with prior statin use.
    Grau AC; George SM
    Am J Med; 2009 May; 122(5):e15; author reply e17. PubMed ID: 19375535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.